Form 8-K · Current Report · Filed 2025-11-03
Kenvue to be Acquired by Kimberly-Clark in $48.7 Billion Deal
Kenvue Inc. has entered into a definitive merger agreement to be acquired by Kimberly-Clark Corporation for an enterprise value of $48.7 billion. The transaction includes $6.8 billion in upfront cash consideration and is expected to close in the second half of 2026. Additionally, Kirk L. Perry was appointed as Kenvue's CEO, and an amendment to the Executive Severance Pay Plan was approved. The merger is anticipated to create a $32 billion global health and wellness leader.
- Filer
- Kenvue Inc. KVUE · NYSE
- Filed
- Accession
- 0001104659-25-105216
- CIK
- 0001944048
- Signal
- High impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Regulation FD Disclosure
Market reaction
Close before filing
$14.37
Next session
+11.1%
Since filing
+33.9%
Latest close
$19.24
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from KVUE reporting the same item, with the next session's move:
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Never miss another KVUE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.